Skip to main content
MedPathMedPath Home
Clinical Trials/KCT0004516
KCT0004516
Not yet recruiting
未知

A multicenter clinical trial to evaluate the efficacy, safety and usability of cyclosporine ophthalmic nanoemulsion 0.05% compared with cyclosporine ophthalmic emulsion 0.1%

Kangbuk Samsung Medical Center0 sites60 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsDiseases of the eye and adnexa

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the eye and adnexa
Sponsor
Kangbuk Samsung Medical Center
Enrollment
60
Status
Not yet recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\) Adult men and women over the age of 19
  • •2\) KCDSG guidelines diagnosed with dry eyes with moderate or higher levels
  • •(1\) Cornea dye score NEI \= 3 points or
  • •(2\) TBUT \=10 sec
  • •3\) Patients who can be monitored for at least 3 months
  • •4\) Those who understand this clinical trial and voluntarily agree to it in writing

Exclusion Criteria

  • •1\) In case ophthalmic cyclosporin preparation is used by the person currently in use or within the last month
  • •2\) Persons with active eye infection such as Stevens\-Johnson syndrome
  • •3\) A person with a past history of corneal transplantation or neuronutitis
  • •4\) Those with eye failure or condition that may affect the analysis of the research result, or those with history
  • •phobiasis, conjunctival scarring caused by semisplastic cornea, sclerosis, lack of serous tear glands, conjunctivitis, corneal esophageal force, etc.
  • •5\) Those who are overreacting to the ingredients (cyclosporin) of the clinical trial
  • •6\) Pregnant or nursing mothers

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 2
Multicenter clinical trial to evaluate the efficacy of rituximab combination chemotherapy for children or AYAswith localized mature B-cell lymphoma
JPRN-jRCTs041210104Sekimizu Masahiro100
Active, not recruiting
Phase 1
Multicentre clinical trial to evaluate the efficacy and safety of dexketoprofen trometamol (50 mg t.i.d.) versus ketorolac (30 mg t.i.d.) and placebo by intravenous route, as part of balanced analgesic therapy with morphine, followed by an oral dosing, in the treatment of postoperative paielective orthopedic surgery (hip arthroplasty)MedDRA version: 7.0Level: PTClassification code 10020096
EUCTR2004-001373-26-ESaboratorios Menarini, S.A
Not yet recruiting
Not Applicable
Multidomain Intervention Via a None-face-to-face Platform in Mild Cognitive ImpairmentMental and behavioural disorders
KCT0007184Inha University Hospital100
Completed
Not Applicable
A multi-centre clinical trial evaluating the safety and functionality of a medical imaging device for tissue review during breast-conserving surgery.Breast CancerCancer - Breast
ACTRN12623000205639OncoRes Medical Pty Ltd30
Completed
Not Applicable
Multicenter clinical study to assess the effectiveness and safety of Aquala liner in total hip arthroplasty (THA)Hip disorders including osteoarthritis
JPRN-UMIN000008730Graduate School of Medicine, The University of Tokyo760